Cio Bulletin
| Company | Management | Description |
|---|---|---|
| ZymIQ Technology | Michael Edelborg Christensen, Co-Founder & CEO |
ZymIQ is at the forefront of enzyme innovation, developing targeted therapeutics and cosmetics that enhance the health and well-being of both humans and animals. Their research is geared towards addressing the issue of antibiotic resistance by creating distinctive antimicrobial products. |
| PBS Biotech | Brian Lee PhD, Founder & CEO |
PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for cell therapy development. |
| Mission Bio | Adam Abate PhD, Co-Founder & CEO |
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. |
| Enable Biosciences | Carolyn Bertozzi PhD, Co-Founder & Chair, SAB |
Enable Biosciences is a pioneering diagnostics company specializing in the development of ultrasensitive immunoassays. Their innovative technology enables the early detection and treatment of autoimmune and infectious diseases. |
| Cellares | Fabian Gerlinghaus, Co-Founder & CEO |
Cellares is pioneering a new way to make living drugs - they're the first of their kind. They're taking a cutting-edge approach to mass-manufacturing cell therapies, and they're using cutting-edge technologies to make it easier for people to get the life-saving therapies they need |
.webp)
 consultants ltd.jpg)
